Pettitt, A. R. (2009). The role of alemtuzumab in chronic lymphocytic leukaemia patients with p53 defects. Hematology Meeting Reports (formerly Haematologica Reports), 1(5). https://doi.org/10.4081/hmr.v1i5.638